Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial

Annals of Internal Medicine

Volumn 134, Issue 8, 2001, Pages 629-636

  Mann, J F E ^a   Gerstein, H C ^a   Poque, J ^a   Bosch, J ^a   Yusuf, S ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RAMIPRIL;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; VASCULAR DISEASE;

EID: 0035901585     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-8-200104170-00007     Document Type: Article

References (20)

1. Abnormalities of kidney function as a cause and a consequence of cardiovascular disease
2. The clinical epidemiology of cardiac disease in chronic renal failure
3. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group
4. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
5. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
6. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
7. The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators
8. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
9. Testing for centre effects in multi-centre survival studies: A Monte Carlo comparison of fixed and random effects tests
10. Relationship between vascular disease and age-associated changes in the human kidney
11. Nephrosclerosis, glycohemoglobin, cholesterol, and smoking in subjects dying of coronary heart disease
12. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis
13. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure
14. Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients
15. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
16. Serum creatinine as a predictor of casdiovascular risk and of evolution of renal function in the HOT study
17. Serum creatinine concentration and risk of casdiovascular disease: A possible marker for increased risk of stroke
18. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature
19. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group
20. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy